Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 151 AL 165

Editorial: Clinical Implementation of Lecanemab: Challenges, Questions and Solutions

Iwatsubo T.

J Prev Alzheimers Dis. 2023;10(3):353-355. doi: 10.14283/jpad.2023.41.

Editorial: Lecanemab: Appropriate Use Recommendations - A Commentary from a European Perspective

Frölich L, Jessen F.

J Prev Alzheimers Dis. 2023;10(3):357-358. doi: 10.14283/jpad.2023.44.

Alzheimer's Disease Treatment: The Search for a Breakthrough

Reiss AB, Muhieddine D, Jacob B, Mesbah M, Pinkhasov A, Gomolin IH, Stecker MM, Wisniewski T, De Leon J.

Medicina (Kaunas). 2023 Jun 4;59(6):1084. doi: 10.3390/medicina59061084.

Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future

Zhang Y, Chen H, Li R, Sterling K, Song W.

Signal Transduct Target Ther. 2023 Jun 30;8(1):248. doi: 10.1038/s41392-023-01484-7.

As a Potential Therapeutic Target, C1q Induces Synapse Loss Via Inflammasome-activating Apoptotic and Mitochondria Impairment Mechanisms in Alzheimer's Disease

Guan PP, Ge TQ, Wang P.

J Neuroimmune Pharmacol. 2023 Sep;18(3):267-284. doi: 10.1007/s11481-023-10076-9. Epub 2023 Jun 29.

Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study

Yu HJ, Dickson SP, Wang PN, Chiu MJ, Huang CC, Chang CC, Liu H, Hendrix SB, Dodart JC, Verma A, Wang CY, Cummings J.

EBioMedicine. 2023 Aug;94:104665. doi: 10.1016/j.ebiom.2023.104665. Epub 2023 Jun 29.

Fatigue in Alzheimer's disease: biological basis and clinical management-a narrative review

Angioni D, Raffin J, Ousset PJ, Delrieu J, de Souto Barreto P.

Aging Clin Exp Res. 2023 Oct;35(10):1981-1989. doi: 10.1007/s40520-023-02482-z. Epub 2023 Jul 3.

Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies

Panza F, Dibello V, Sardone R, Castellana F, Zupo R, Lampignano L, Bortone I, Stallone R, Cirillo N, Damiani C, Altamura M, Bellomo A, Daniele A, Solfrizzi V, Lozupone M.

Expert Opin Investig Drugs. 2023 Jul-Dec;32(7):625-634. doi: 10.1080/13543784.2023.2233892. Epub 2023 Jul 10.

A Comprehensive Review on Inorganic Nanoparticles as Effective Modulators of Amyloidogenesis

Chakraborty D, Mukherjee A, Sarkar N.

Protein Pept Lett. 2023;30(8):640-652. doi: 10.2174/0929866530666230705153229.

Under the umbrella of depression and Alzheimer's disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?

Fonseca C, Ettcheto M, Bicker J, Fernandes MJ, Falcão A, Camins A, Fortuna A.

Ageing Res Rev. 2023 Sep;90:101998. doi: 10.1016/j.arr.2023.101998. Epub 2023 Jul 5.

Social robotics to support older people with dementia: a study protocol with Paro seal robot in an Italian Alzheimer's day center

Bevilacqua R, Maranesi E, Felici E, Margaritini A, Amabili G, Barbarossa F, Bonfigli AR, Pelliccioni G, Paciaroni L.

Front Public Health. 2023 Jun 21;11:1141460. doi: 10.3389/fpubh.2023.1141460. eCollection 2023.

Iron metabolism: An emerging therapeutic target underlying the anti-Alzheimer's disease effect of ginseng

Li N, Duan YH, Chen L, Zhang K.

J Trace Elem Med Biol. 2023 Sep;79:127252. doi: 10.1016/j.jtemb.2023.127252. Epub 2023 Jun 24.

Spontaneous and familial models of Alzheimer's disease: Challenges and advances in preclinical research

Ulaganathan S, Pitchaimani A.

Life Sci. 2023 Sep 1;328:121918. doi: 10.1016/j.lfs.2023.121918. Epub 2023 Jul 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias